RBM11P1

Across TCGA pan-cancer cohorts, RBM11P1 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RBM11P1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RBM11P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RBM11P1 expression acts as an unfavorable survival marker.

LUAD, UCEC, and BRCA are the cancer types where RBM11P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	IV	0.047	0.565	<.001	72	view →
UCEC	DFS	Tertile	II,III,IV	0.085	0.518	<.001	60	view →
BRCA	OS	Tertile	II,III,IV	0.743	0.916	.002	48	view →
MESO	OS	Tertile	III,IV	0.337	0.584	.012	45	view →
PAAD	OS	Tertile	II,III,IV	0.246	0.561	.003	36	view →
OV	DFS	Tertile	IV	0.151	0.481	.005	36	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	36	view →
LGG	OS	Tertile	All	0.396	0.899	<.001	36	view →
THCA	DFS	Tertile	All	0.573	0.868	.037	18	view →
UCS	DFS	Tertile	All	0.208	0.541	.014	18	view →
LUSC	OS	Tertile	III,IV	0.054	0.768	<.001	18	view →
LIHC	OS	Tertile	All	0.485	0.791	.004	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RBM11P1–LUAD (DFS)

Open the LUAD breakdown →